Remdesivir
Jump to navigation
Jump to search
 Remdesivir(drug)   | |
|---|---|
 | |
| Interest of | Bryan Ardis |
| Expensive COVID drug promoted by Anthony Fauci | |
Remdesivir is a drug developed by Gilead and promoted by Anthony Fauci for COVID-19.
Contents
Origins
The drug was developed with US government grants. MintPresNews quoted a figure of $70 million,[1] other estimates range as high as $6.5 billion.[2]
Efficacy
A study suggested that the drug did not affect the COVID case fatality rate, but reduced the average hospital visit for COVID-19 patients from 15 days to 11 days when compared to a placebo.[1]
Pricing
Developers Gilead faced criticism for charging $2,340 to $3,120 for a five day course of the drug.[1][2]
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
